•
Mar 31, 2022

iTeos Therapeutics Q1 2022 Earnings Report

Total Revenue
$153M
EPS
$1.82
Previous year: -$0.39
-566.7%
Gross Profit
$152M
Cash and Equivalents
$824M
Previous year: $321M
+156.4%
Free Cash Flow
-$24.2M
Previous year: -$14.9M
+62.9%
Total Assets
$850M
Previous year: $333M
+155.4%

iTeos Therapeutics

iTeos Therapeutics